Drug information for HALOBETASOL PROPIONATE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CREAM; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
FOUGERA PHARMS
77001
2004-12-30 Letter
CREAM; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
PERRIGO ISRAEL
77123
2004-12-23 Letter
CREAM; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
TARO
77227
CREAM; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
G AND W LABS
78162
OINTMENT; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
PERRIGO
76872
2004-12-30 Letter
OINTMENT; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
FOUGERA PHARMS
76903
2004-12-30 Letter
OINTMENT; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
TARO
76994
2004-12-30 Letter
OINTMENT; TOPICAL
0.05%
Discontinued
HALOBETASOL PROPIONATE
halobetasol
ACTAVIS MID ATLANTIC
77109
OINTMENT; TOPICAL
0.05%
Prescription
AB
HALOBETASOL PROPIONATE
halobetasol
G AND W LABS
77721
Drug Adverse Effects information for HALOBETASOL PROPIONATE
Role code
Indications
Reaction
# Reports
C
ACNE
CHOLECYSTITIS CHRONIC
2
C
ACNE
HEPATIC NECROSIS
2
C
ACNE
HEPATIC STEATOSIS
2
C
ACNE
HEPATOMEGALY
2
C
ACNE
INJURY
2
C
ACNE
MENTAL DISORDER
2
C
ACNE
PAIN
2
C
ACNE
SPLENOMEGALY
2
C
PREMENSTRUAL SYNDROME
CHOLECYSTITIS CHRONIC
2
C
PREMENSTRUAL SYNDROME
HEPATIC NECROSIS
2
C
PREMENSTRUAL SYNDROME
HEPATIC STEATOSIS
2
C
PREMENSTRUAL SYNDROME
HEPATOMEGALY
2
C
PREMENSTRUAL SYNDROME
INJURY
2
C
PREMENSTRUAL SYNDROME
MENTAL DISORDER
2
C
PREMENSTRUAL SYNDROME
PAIN
2
C
PREMENSTRUAL SYNDROME
SPLENOMEGALY
2
Ads by Google